Gabriela Tomescu

Corporate Officer/Principal presso Apneon, Inc.

Consumer Services

Health Technology

Profilo

Gabriela Tomescu is currently working as the Director of Intellectual Property at Apneon, Inc. She has an undergraduate and graduate degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from The Ohio State University, and a graduate degree from Georgetown University.

Posizioni attive di Gabriela Tomescu

Società	Posizione	Inizio
Apneon, Inc. Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA.	Corporate Officer/Principal	01/09/2005

Tutte le posizioni attive di Gabriela Tomescu

Formazione di Gabriela Tomescu

The Ohio State University	Undergraduate Degree
The Trustees of Columbia University in The City of New York	Graduate Degree
Georgetown University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Gabriela Tomescu

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Apneon, Inc. Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA.	Health Technology